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Mutations of SLC4A1 (AE1) encoding the kidney anion (Cl
-/HCO3
-) exchanger 1 (kAE1 or band 3) can result 
in either autosomal dominant (AD) or autosomal recessive (AR) distal renal tubular acidosis (dRTA). The 
molecular mechanisms associated with SLC4A1 mutations resulting in these different modes of inheritance 
are now being unveiled using transfected cell systems. The dominant mutants kAE1 R589H, R901X and 
S613F, which have normal or insignificant changes in anion transport function, exhibit intracellular retention 
with endoplasmic reticulum (ER) localization in cultured non-polarized and polarized cells, while the domi-
nant mutants kAE1 R901X and G609R are mis-targeted to apical membrane in addition to the basolateral 
membrane in cultured polarized cells. A dominant-negative effect is likely responsible for the dominant dis-
ease because heterodimers of kAE1 mutants and the wild-type protein are intracellularly retained. The reces-
sive mutants kAE1 G701D and S773P however exhibit distinct trafficking defects. The kAE1 G701D mutant 
is retained in the Golgi apparatus, while the mis-folded kAE1 S773P, which is impaired in ER exit and is 
degraded by proteosome, can only partially be delivered to the basolateral membrane of the polarized cells. 
In contrast to the dominant mutant kAE1, heterodimers of the recessive mutant kAE1 and wild-type kAE1 
are able to traffic to the plasma membrane. The wild-type kAE1 thus exhibits a ‘dominant-positive effect’ 
relative to the recessive mutant kAE1 because it can rescue the mutant proteins from intracellular retention to 
be expressed at the cell surface. Consequently, homozygous or compound heterozygous recessive mutations 
are required for presentation of the disease phenotype. Future work using animal models of dRTA will pro-
vide additional insight into the pathophysiology of this disease. 
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Primary distal renal tubular acidosis (dRTA) is a clinical 
syndrome characterized  by  impairment of acid secretion 
by α-intercalated cells in the distal nephron and collecting 
tubule, resulting in decreased net acid excretion and inabil-
ity of kidney to lower urinary pH <5.5 in spite of sponta-
neous academia or after acid loading (Batlle et al 2001; 
Alper , 2002; Herrin, 2003).  The decreased net acid excre-
tion  attributable  to  decreased  ammonium  and  titratable 
acid excretion leads to a positive acid balance and hyper-
chloremic  metabolic  acidosis.  The  presence  of  chronic  
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metabolic acidosis consequently decreases renal excretion 
of citrate (hypocitraturia) while increases calcium excre-
tion (hypercalciuria), creating a favorable environment for 
urinary stone formation and nephrocalcinosis.  The other 
associated  abnormalities  include  hypokalemia leading  to 
muscle weakness, and metabolic bone disease (rickets or 
osteomalacia). The disease can be caused either by a de-
fect in the H
+-ATPase, which is responsible for acid (H
+) 
secretion  at  the  apical  membrane  of  the  epithelial  α-
intercalated cells or by an abnormality of the kidney anion 
exchanger 1 (kAE1) that functions in chloride (Cl
-) and 
bicarbonate  (HCO3
-)  anion  exchange  at  the  basolateral 
membrane (Figure 1).  The defects of these two proteins 
may occur from mutations of the responsible genes caus-
ing hereditary dRTA. Mutations of at least two genes en-
coding two subunits (B1 and a4) of H
+-ATPase have been 
reported  to  cause  autosomal  recessive  dRTA  with  sen-
sorineural deafness or normal hearing (Karet et al, 1999; 
Smith et al, 2000; Stover et al, 2002; Ruf et al, 2003).  The 
genes that encode B1 subunit in V1 (catalytic) domain and 
a4 subunit in Vo (transmembrane) domain of H
+-ATPase 
are  ATP6V1B1  (MIM  192132)  located  on  chromosome 
2p13.1 and ATP6V0A4 (MIM 605239) situated on chro-
mosome 7q33-q34, respectively.  Also, mutations in hu-
man solute carrier family 4, member 1 (SLC4A1) or anion 
exchanger 1 (AE1) gene (MIM 109270) may cause dRTA.  
SLC4A1 located on chromosome 17q21-q22 encodes both 
erythroid (eAE1, band 3) and kidney (kAE1) isoforms of 
AE1 protein.  Thus, SLC4A1 mutations shows pleiotrophic 
effects resulting in two distinct and seemingly unrelated 
disorders, red cell abnormalities (e.g., hereditary spherocy-
tosis and ovalocytosis) and dRTA. 
 
An  abnormality  of  kAE1  that  mediates  chlo-
ride/bicarbonate  (Cl
-/HCO3
-)  exchange  at  the  basolateral 
membrane of the α-intercalated cells can lead to a defect 
in  bicarbonate  (HCO3
-)  extrusion  across  this  membrane 
and to its intracellular accumulation. To maintain intracel-
lular acid-base and electroneutal balances, the cells would 
reserve  acid  or  hydrogen  ion  (H
+)  instead  of  secreting 
through the apical membrane. Consequently, the intracel-
lular accumulation of both bicarbonate and hydrogen ions 
would  inhibit  the  dissociation  of  carbonic  acid  (H2CO3) 
(Figure  1).  The  failure  of  hydrogen  ion  (H
+)  secretion 
through the apical membrane into the tubular lumen due to 
a kAE1 defect will eventually result in dRTA. 
 
It  was  previously  unknown  why  mutations  of  SLC4A1 
cause both autosomal dominant (AD) (Bruce et al, 1997; 
Jarolim et al, 1998; Karet et al, 1998; Weber et al, 2000; 
Sritippayawan et al, 2003; Cheidde et al, 2003) and auto-
somal  recessive  (AR)  dRTA  (Tanphaichitr  et  al,  1998; 
Vasuvattakul et al, 1999; Bruce et al, 2000; Ribeiro et al, 
2000;  Yenchitsomanus  et  al,  2002;  Sritippayawan  et  al, 
2004).  During the past several years, several groups have 
begun  to  unravel  the  molecular  mechanisms  of  dRTA 
caused by SLC4A1 mutations presenting in these two dif-
ferent manners of inheritance. We have recently demon-
strated that dominant and recessive dRTA phenotypes as-
sociated with SLC4A1 mutations are determined by differ-
ent  behaviors  in  the  intracellular  trafficking  of  het-
erodimers  between  mutant  and  wild-type  kAE1.  The 
dominant kAE1 mutants result in intracellular retention of 
the wild-type kAE1, the so called ‘dominant-negative ef-
fect’,  whereas  the  wild-type  kAE1  exhibits  ‘dominant-
positive effect’ relative to the recessive mutant kAE1 be-
cause it can rescue the recessive mutant kAE1 to express 
on the cell surface.  We have therefore distinguished the 


























Figure 1.  Schematic diagram of the α-intercalated cell in the distal nephron.  H
+-ATPase and H
+/K
+-ATPase, involving in acid (H
+) 
secretion (in exchange with K
+ in the latter), are present at the apical membrane, while kAE1, functioning in chloride/bicarbonate 
(Cl
-/HCO3
-) exchange, is located at the basolateral membrane.  H
+ and HCO3
- for apical secretion and basolateral reabsorption are 
dissociated from H2CO3, generated from hydration of carbon dioxide (CO2), which is catalyzed by carbonic anhydrase (CA) II.  
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SLC4A1 AND ENCODED PROTEINS 
 
SLC4A1 
The human SLC4A1 or AE1 gene encoding the anion ex-
changer  1  (AE1  or  band  3)  is  located  on  chromosome 
17q21-q22 encompassing approximately  20  kb and con-
sisting of 20 exons separated by 19 introns.  The gene con-
tains no TATA or CCAAT boxes in its upstream region 
(Tanner et al, 1988; Lux et al, 1989; Sahr et al, 1994) but 
consists  of  transcription  factor  consensus  binding  sites, 
activator  protein  1  (AP1),  activator  protein  2  (AP2), 
CACCC boxes, GATA (erythroid factor 1), and E-boxes in 
this  region.  Instead,  the  TATA  and  CCAAT  boxes  are 
found in intron 3. The structure of the gene showed exten-
sive similarity to that of mouse AE1, with a high degree of 
conservation  of  exon/intron  junctions  (Sahr  et  al,  1994; 
Schofield et al, 1994). The human SLC4A1 encodes both 
eAE1 and kAE1 isoforms by using different promoters and 
alternative  splicing.  While  eAE1  mRNA  is  transcribed 
from  all  exons  by  using  its  upstream  promoter,  kAE1 
mRNA is transcribed by using the promoter in intron 3.  
The  eAE1  cDNA  sequence  comprises  4,906  nucleotides 
(nt), excluding its poly (A) tail. The kAE1 mRNA lacks 
the sequences of exons 1-3 of the eAE1 transcript but con-
tains a part of intron 3 (designated as exon K1) in its 5’ 
untranslated region (5’ UTR) and the complete exon 4-20 
sequences  with  the  translation  initiation  (ATG)  site  for 
methionine (Met) at codon 66 (Kollert-Jöns et al, 1993).  
The downstream end of exon 20 is defined as the RNA 
cleavage site or poly A addition site. A consensus poly A 
signal (AATAAA) is located 20 nucleotides upstream of 
the RNA cleavage site. 
 
Expression and function of eAE1 and kAE1 
The human eAE1 or band 3 is a multifunctional polytopic 
membrane glycoprotein containing 911 amino acids (Tan-
ner et al, 1988; Lux et al, 1989) with molecular weight 
(MW) of approximately 95 kDa carrying a single glycosy-
lation site at Asn642. It is expressed on erythrocytes at a 
high copy number of approximately 1x10
6 copies per cell 
and exists in mature red cells as a mixture of dimers and 
tetramers.  The  eAE1  tetramers  bind  to  ankyrin  and  cy-
toskeleton proteins, a binding which is critical for mainte-
nance of the biconcave disc shape of red blood cells.  In 
ankyrin-deficient cells, AE1 is present mainly as dimers 
(Jennings, 1984). In peripheral tissues, eAE1 functions in 
electroneutral anion (Cl
-/HCO3
-) exchange by transporting 
bicarbonate (HCO3
-) out of erythrocytes in exchange for 
chloride (Cl
-) uptake into the cell, but it operates in the 
reverse mode in the lung. kAE1 which lacks 65 N-terminal 
amino-acids of eAE1, is expressed at the basolateral sur-
face of the α-intercalated cells in the distal nephron (Alper 
et al, 1989; Kollert-Jöns et al, 1993). It provides a major 
exit route for HCO3
- in exchange for Cl
- across the baso-
lateral membrane of the α-intercalated cells, while hydro-
gen ion (H
+) is secreted through the apical membrane of 
these cells into the tubular lumen. 
 
Structure of eAE1 and kAE1 
eAE1 comprises two main domains that are structurally and 
functionally  distinct.  The  40-kDa  N-terminal  cytoplasmic 
domain, residues 1-360, involved in functions unrelated to 
anion transport, but acts as a membrane anchorage site for 
the red cell skeleton through the interactions with ankyrin, 
band 4.1, and band 4.2. This domain of eAE1 also binds to 
the glycolytic enzyme complex (Campanella et al, 2005). 
The  N-terminal  cytoplasmic  domain  of  kAE1,  65  amino 
acids shorter than that of eAE1, does not bind to ankyrin or 
glycolytic enzymes (Wang et al, 1995; Zhang et al, 2000) 
and its interacting proteins in the α-intercalated cells remain 
to be identified. The 50-kDa C-terminal integral membrane 
domain with 12-13 transmembrane (TM) spans, from resi-
dues 361 to 882, mediates in Cl
-/HCO3
- exchange (Groves 
and Tanner, 1999). The anion transport is inhibited by 4, 4’-
diisothiocyanostilbene-2-2’, disulfonic acid (DIDS), which 
covalently binds to extracellular Lys539 in TM5 and can 
crosslink to Lys851 in TM12 (Kawano et al, 1988; Okubo 
et al, 1994). Both eAE1 and kAE1 has a short acidic cyto-
plasmic C-terminal tail (residues 883-911), containing bind-
ing sites for carbonic anhydrase (CA) II (Vince and Reith-
meier, 1998; Reithmeier, 2001) and for protein complexes 
involving in the targeting of kAE1 to the basolateral mem-
brane of kidney α-intercalated cells (Devonald et al, 2003a; 
Toye et al, 2004). 
 
AE1 – a transport metabolon 
The short acidic cytoplasmic C-terminal tail (residues 883-
911) of eAE1 and kAE1 binds to CA II.  This binding fa-
cilitates and maximizes bicarbonate transport by channel-
ing substrate from CAII directly to AE1 (Reithmeier RAF, 
2001; Sterling et al, 2001).  Bicarbonate (HCO3
-) from the 
breakdown of carbonic acid (H2CO3) generated from hy-
dration  of carbon  dioxide  (CO2)  by  CAII  is transported 
across the cell membrane in exchange for chloride (Cl
-) by 
AE1. It was demonstrated in transfected human embryonic 
kidney (HEK) 293 cells that the binding between the cyto-
plasmic  C-terminal  region  of  AE1  and  CAII  provides 
maximal anion  transport activity  of AE1 (Sterling et al, 
2001;  Sterling  and  Casey,  2002).  The  binding  motif  of 
AE1 is acidic L886DADD890, interacting with a basic his-
tidine  cluster  at  the  N-terminus  of  CAII  (Vince  and 
Reithmeier, 1998; Vince et al, 2000). Leu886 on AE1 is 
highly  conserved  among  anion  exchangers  (Vince  and 
Reithmeier, 1998) and important for the binding, suggest-
ing the involvement of a hydrophobic amino acid residue 
in the interaction. The  binding motif close to  the mem-
brane  would  ideally  position  CAII  for  coordinating  its 
function with AE1. The association of CAII – a soluble 
enzyme and AE1 – a membrane transporter is regarded as 
an example of a functional transport ‘metabolon’ (Reith-
meier,  2001),  a  weakly  associated  protein  complex  in-
volved in a metabolic and transporting pathway to facili-
tate movement of metabolite directly from one protein to 
the  next.  Treatment  of  AE1-transfected  HEK  293  cells 
with the CA inhibitor, azetazolamide, gave rise to almost 
complete inhibition of anion transport activity, and block-
ing of CAII binding to AE1 resulted in a decrease in Cl
-
/HCO3
- transport (Sterling et al, 2001). 
 
Targeting of eAE1 and kAE1 
Trafficking of eAE1 from its biosynthesis site and in-
tracellular  compartments  to  the  red  cell  membrane  is 
facilitated by glycophorin A (GPA), a 36 kDa glycopro-
tein of the red cell membrane (Bruce et al, 1994). The 
importance of the N-terminus of kAE1 in protein target-
ing has recently been described (Toye et al, 2004). In  
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stably  transfected  Madin-Darby  canine  kidney 
(MDCK) cells expressing the AE1 membrane domain 
(residues 361-911), lacking the N-terminal domain, the 
protein was localized to the apical membrane, suggest-
ing  that elements within  the  N-terminal sequence  are 
required  for  the  basolateral  targeting  of  kAE1.  
Y359KGL362  is  a  potential  tyrosine-targeting  motif  in 
the N-terminus of kAE1. 
 
A motif (Y904DEV907) is present on the cytoplasmic C-
terminal tail of human AE1. This motif conforms to a 
subset of tyrosine-based signals, YXXØ motif (where Y 
is tyrosine, X is any amino acid, and Ø is hydrophobic 
amino acid) (Canfield et al, 1991), which is known to 
be involved in localization to coated pits and clathrin-
mediated  endocytosis,  and  also  in  basolateral  sorting 
(Matter et al, 1994; Lin et al, 1997; Distel et al, 1998). 
Many membrane proteins are usually sorted to the baso-
lateral  surface  through  interactions  of  tyrosine-based 
signal motifs in their cytoplasmic domains with adap-
tor-protein  complexes  (Bonifacino  and  Dell'Angelica, 
1999; Folsch et al, 1999). This motif plays an important 
role in kAE1 distribution in polarized cells. Tyr904 in 
the YXXØ motif of  kAE1 has been examined for the 
basolateral  signal  in  MDCK  cells  and  rat  inner  me-
dullary  collecting  duct  (IMCD)  cells  (Devonald  et  al, 
2003a;  Toye  et  al,  2004).  kAE1  with  substitution  of 
Tyr904 by alanine (Y904A) or with an 11 amino acid 
deletion (R901X) is mistargeted to the apical membrane 
(Devonald et al, 2003a; Toye et al, 2004). The YXXØ 
motif is recognized by the µ subunit of the adaptor pro-
tein (AP) complexes of AP-1, AP-2, AP-3, and AP-4, 
(Ohno et al, 1995; Bonifacino and Dell'Angelica, 1999; 
Bonifacino and Traub, 2003), especially AP-1B which 
is  specific  to  polarized  epithelial  cells  (Ohno  et  al, 
1999; Folsch et al, 1999). Nevertheless, AP-1B may not 
be involved in kAE1 targeting as shown in a study us-
ing  renal  epithelial  cell  line  from  porcine  kidneys 
(LLC-PK1)  lacking  the  µ1B  subunit  (Devonald  et  al, 
2003a; Toye et al, 2004). 
 
The acidic patch (DE) at positions 905-906 following 
Tyr904 and the last 4 amino acids (A908MPV911) at the 
C-terminus  may  also  be  required  for  trafficking  and 
localization of kAE1. The A908MPV911 motif has been 
proposed  as  a  potential  PDZ  protein  binding  domain 
(XØXØ;  where  Ø  represents  a  hydrophobic  amino 
acid). Replacement of the acidic patch (DE) with two 
alanines (AA), or deletion of the last 4 amino acids at 
the  C-terminus  (AE1∆908-911)  showed  non-polarized 
distribution to apical membrane and some intracellular 
localization in transfected polarized MDCK and IMCD 
cells (Devonald et al, 2003b). A similar result was ob-
tained  from  the  trafficking  study  of  the  deletion  of  5 
amino acids at the C-terminus of AE1 (AE1∆907-911) 
in  transiently  transfected  HEK  293  cells  and  non-
polarized LLC-PK1 cells (Cordat et al, 2003). The mo-
tifs present in the C-terminal tail of kAE1 may also be 
involved in endocytosis and retention in the basolateral 
membrane  via  interaction  with the  actin  cytoskeleton.  
However, the proteins that interact with these motifs at 
the C-terminus of kAE1 in the α-intercalated cells have 
not yet been identified. 
HUMAN DISEASES CAUSED BY SLC4A1 MUTATIONS 
 
Hereditary spherocytosis and dRTA 
Mutations in eAE1 can result in hereditary spherocytosis 
(HS),  a  common  inherited  hemolytic  anemia  with  the 
presence of osmotically fragile spheroidal-shape erythro-
cytes and splenomegaly (Bruce and Tanner, 1999).  Ap-
proximately 20% of HS cases are caused by dominantly 
inherited heterozygous SLC4A1 mutations (Jarolim et al, 
1996; Bruce and Tanner, 1996; Tanner MJ, 1997; Tse and 
Lux,  1999).    The  link  between  AE1-deficient  HS  and 
dRTA was investigated (Rysava et al, 1997) and it was 
found  that  the  patients  with  AE1-deficient  HS  had  no 
dRTA although two out of eight patients studied had an 
incomplete form of dRTA, defined by acid secretion de-
fect after an acid load (urine pH >5.5) but absence of clini-
cal manifestation.  These two patients, mother and daugh-
ter, carried a previously identified SLC4A1 mutation caus-
ing band 3 PRIBRAM, a substitution of G by T at the po-
sition +1 of intron 12 (IVS12+1G>T), leading to the reten-
tion of intron 12 sequence following the normal codon 477 
and encoding 7 novel amino acids and a termination con-
don (TGA) at the position 8
th triplet of intron 12 (Jarolim 
et al, 1996).  This has led to the conclusion that SLC4A1 
HS mutations are not normally sufficient to cause full ex-
pression of dRTA (Rysava et al, 1997).  However, severe 
HS and dRTA with complete absence of eAE1 was found 
in the patient with homozygous SLC4A1 V488M mutation 
(band 3 Coimbra) (Ribeiro et al, 2000). 
 
The spectrum of AE1 deficiency in HS ranges from 20–
40% decrease to complete absence of red cell AE1 con-
tent.  These usually occur from nonsense, frameshift, and 
missense mutations of SLC4A1 (Iolascon, et al 1998).  The 
missense mutations may cause a greater decrease in AE1 
expression  in  red  cells,  probably  due  to  a  dominant-
negative  effect  (Dhermy  et  al,  1999).    Several  SLC4A1 
mutations that alter amino acids in the cytoplamic domain 
of AE1 may change binding sites for ankyrin, band 4.2, α- 
and  β-spectrins (Eber  et  al,  1996;  Alloisio  et  al,  1997).  
Additionally,  the  SLC4A1  E40K  and  P327R  mutations 
affecting the cytosolic domain of AE1 are associated with 
a decreased band 4.2 without loss of AE1 content (Jarolim 
et al, 1992; Rybicki et al, 1993).  From studies in AE1 
knock-out mice, it has been hypothesized that AE1 defi-
ciency  causes  reduction  of  protein–lipid  and  protein–
protein interactions in the red cell membrane, weakening 
the connections between the membrane and cytoskeleton 
and  thereby  causing  blebbing  of  AE1-free  portions  of 
membrane (Peters et al, 1996). This would cause the re-
duction of surface area to volume ratio and the spheroidal 
shape of red cells. 
 
The  effect  of  seven  SLC4A1  HS-missense  mutations 
(L707P,  R760Q,  R760W,  R808C,  H834P,  T837M,  and 
R870W),  located  within  the  transmembrane  domains  of 
AE1,  on  the  biosynthesis  and  functional  expression  of 
AE1  in  transfected  HEK  293  cells,  has  been  examined 
(Quilty  and  Reithmeier,  2000).  All  seven  HS  mutations 
caused  the  AE1  protein  to  mis-fold  and  be  retained  in-
tracellularly.  However, there was no change in the oli-
gomeric state or the half-life of the mutant AE1.  Intracel-
lular retention of HS mutant AE1 would lead to destruc- 
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tion  of  the  protein  during  erythroid  development  and 
would  account  for  the  lack  of  HS  mutant  AE1  in  the 
plasma  membrane  of  the  mature  red  cell.  The  possible 
explanation for lack of the dRTA phenotype of SLC4A1 
HS mutations is that while these mutations affect eAE1 in 
the erythroid cells, they may have little  or  no effect on 
kAE1  in  the  kidney  α-intercalated  cells.  However,  it  is 
also likely that some mutations may result in both HS and 
AR  dRTA,  which  in  the  heterozygous  condition  would 
result  in  HS  phenotype  without  dRTA  symptoms.  The 
combined HS and dRTA symptoms may  only appear in 
patients  carrying  two  mutant  alleles.  Homozygous 
SLC4A1 V488M mutation causing severe HS and dRTA 
(Ribeiro et al, 2000) is a good example that supports this 
explanation. 
 
Southeast Asian ovalocytosis and dRTA 
Southeast  Asian  ovalocytosis  (SAO)  is  a  morphological 
red cell abnormality caused by a mutational deletion of 27 
base-pair  (bp)  in  exon  11  of  SLC4A1  leading  to  an  in-
frame 9 amino acid deletion involving Ala400-Ala408 of 
eAE1, at the junction between the N-terminal domain and 
the first  transmembrane  span (Jarolim  et  al,  1991).  The 
mutant protein is inactive for anion transport function and 
seems to have an increased  tendency to form oligomers 
which  exhibit  increased  association  with  the  membrane 
cytoskeleton (Liu et al, 1995), increasing membrane rigid-
ity  and  decreasing  red  cell  deformability.  The  deletion 
impairs the ability of the first transmembrane segment to 
integrate into the membrane; however, once integrated it 
assumes a transmembrane disposition (Cheung and Reith-
meier,  2005).  SAO  is  widespread  in  the  Southeast  Asia 
regions including southern Thailand, Malaysia, Indonesia, 
the Phillipines, and Papua New Guinea (PNG). Its preva-
lence  is  about  3%  in  the  southern  Thai  population 
(Yenchitsomanus  et  al,  2003)  but  higher  in  Indonesian 
islands and parts of PNG (Nurse et al, 1992) and it is as 
high as 35% in the population of the north coast of PNG 
(Mgone et al, 1996).  SAO is found only in the heterozy-
gous state of SLC4A1 ∆Ala400-∆Ala408 deletion, its ho-
mozygous  state  is  likely  to  be  lethal  (Liu  et  al,  1994; 
Mgone  et  al,  1996),  for  the  fetus  carrying  homozygous 
SAO mutation may not survive in utero. High frequencies 
of SLC4A1 SAO mutation in Southeast Asian populations 
may  result  from  a  selective  survival  advantage  against 
malaria infection because the patient with SAO is less sus-
ceptible to cerebral malaria (Allen et al, 1999). 
 
The heterozygous SLC4A1 SAO mutation does not cause 
dRTA (Vasuvattakul et al, 1999; Bruce et al, 2000). The 
effect of the SAO deletion on stability and trafficking of 
AE1  and  kAE1  was  examined  in  transfected  HEK  293 
cells and kAE1 in MDCK cells (Cheung et al, 2005).  Ex-
pression levels and stabilities of SAO proteins were sig-
nificantly reduced in HEK 293 cells. The mutant AE1 pro-
tein was retained intracellularly in these cells without de-
tection at the cell surface.  The mutant protein is misfolded 
but its homodimers and heterodimers with the normal pro-
teins could be formed. While kAE1 was localized to the 
cell surface or the basolateral membrane after polarization 
of MDCK cells, kAE1 SAO was retained intracellularly.  
In co-expression of kAE1 SAO and kAE1 in MDCK cells, 
kAE1  SAO  was  partly  retained  intracellularly  and  co-
localized with kAE1 at the cell surface. Thus, Cheung et al 
(Cheung et al, 2005) have proposed that in the kidney of 
heterozygous  SAO  patients,  homodimers  of  kAE1  and 
heterodimers of kAE1 SAO and kAE1 traffic to the baso-
lateral  membrane  of  the  α-intercalated  cells,  while 
homodimers of kAE1 SAO are retained in the endoplasmic 
reticulum and rapidly degraded. This would result in suffi-
cient expression of kAE1 to maintain adequate bicarbonate 
reabsorption and proton secretion without the phenotype 
of dRTA. 
 
However, co-existence of SAO and dRTA results from com-
pound heterozygous SLC4A1 SAO and another dRTA muta-
tion present on the opposite allele, indicating an autosomal 
recessive  manner  of  inheritance  (Vasuvattakul  et al,  1999; 
Bruce et al, 2000; Wrong et al, 2002; Yenchitsomanus, 2003). 
Compound  heterozygous  SLC4A1  SAO/G701D  mutations 
are frequently observed in pediatric patients in the popula-
tions  of  Thailand  and  other  Southeast  Asian  countries 
(Vasuvattakul et al, 1999; Bruce et al, 2000; Wrong et al, 
2002; Yenchitsomanus, 2003). Other genotypes occurring 
from compound  heterozygous  SLC4A1  mutations  with  or 
without SAO were also noted (Bruce et al, 2000; Sritippay-
awan et al, 2004).  The details of these compound heterozy-
gous SLC4A1 mutations are discussed in the section of AR 
dRTA. 
 
Autosomal dominant distal renal tubular acidosis (AD 
dRTA) 
The  association  between  SLC4A1  mutations  and  AD 
dRTA  has  been  well  documented  (Bruce  et  al,  1997; 
Jarolim et al, 1998; Karet et al, 1998; Weber et al, 2000; 
Sritippayawan et al, 2003). The most common mutation 
resulting  in  AD  dRTA  is  a  missense  substitution  of 
Arg589, a conserved residue located within the region of 
TM6 and TM7 of AE1 protein, predominantly by histidine 
(R589H)  or  cysteine  (R589C)  and  rarely  by  serine 
(R589S) (Table 1 and Figure 2). The presence of muta-
tions at the same position in several populations with alle-
lic heterogeneity and at least two de novo mutations (Karet 
et al, 1998; Sritippayawan et al, 2003) makes it unlikely 
that this frequently observed R589H mutation will result 
from founder effect but is more likely to result from recur-
rent mutations.  This led to the suggestion that codon 589 
(CGC)  is  a  ‘mutational  hotspot’  of  SLC4A1  (Sritippay-
awan et al, 2003), and the mechanism of recurrent muta-
tions probably involves methylation and deamination that 
alter cytosine (C) to thymine (T) in the CpG dinucleotides 
(Wrong et al, 2002; Sritippayawan et al, 2003). 
 
The first three SLC4A1 mutations to be identified in AD 
dRTA (R589H,  R589C,  and  S613F)  were  heterozygous, 
and  had  normal  red  cell  morphology  and  eAE1 content 
(Bruce et al, 1997).  Red cell anion transport activity of the 
patients with the R589H or R589C mutations were slightly 
reduced (approximately 80% of normal) while those of the 
patients  with  S613F  mutation  were  greatly  increased 
(262% of normal).  When expressed in Xenopus oocytes, 
only  eAE1  R589H  showed  decreased  (40%  of  normal) 
chloride  influx  activity  whereas  kAE1  R589H  showed 
normal activity.  The kAE1 R589C and S613F mutants did 
not show a significantly different transport function com-
pared  with  wild-type  kAE1.  Co-expression  of wild-type   
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Table 1.  SLC4A1 mutations causing autsomal dominant (AD) and autosomal recessive (AR) distal renal tubular acidosis (dRTA) 
 
Mutations causing AD dRTA  Mutations causing AR dRTA 









          A888L+889X 
               R901X (Walton) 
                        SAO (∆Ala400-Ala408)
c 
                        V488M (Coimbra) 
                        R602H (Songkla I) 
                       G701D (Bangkok I) 
                       S773P (Siriraj I) 




aBand 3 PRIBRAM is a mutation owning to a SLC4A1 IVS12+1G>T substitution (see text).  Heterozygous band 3 PRIBRAM results in incomplete 
dRTA. 
bHeterozygous A858D mutation causes incomplete dRTA; complete dRTA is occurred from its compound heterozygous conditions with other reces-
sive mutations (e.g. A858D/SAO and ∆V850/A858D). Thus, the assignment of band 3 PRIBRAM and A858D mutations under AD dRTA may be 
questionable. 
cSAO, Southeast Asian ovalocytosis - an in-frame nine-amino acid deletion (∆Ala400-Ala408), is regarded as a mutation causing AR dRTA because 
its compound heterozygous conditions with G701D or other recessive mutations results in dRTA with ovalocytic red cells.  Homozygous SAO has 
not been reported, and is believed to be lethal in utero.  
(Bruce et al, 1997 & 2000; Cheidde et al, 2003; Jarolim et al, 1998; Karet et al, 1998; Ribeiro et al, 2000; Rungroj et al, 2004; Sritippayawan et al, 




and mutant AE1 did not show any effect on the chloride 
uptake function in Xenopus oocyte, suggesting that domi-
nant dRTA does not result from a change in transport ac-
tivity.    The  conserved  Arg589  is  located  in  the  region 
close to TM6 and TM7, which is important for anion bind-
ing activity, and S613F change may distort the conforma-
tion  of  the  cytoplasmic  loop  between  TM6  and  TM7 
which contains the putative anion binding site. 
 
Three further unrelated families with the SLC4A1 R589H 
mutation  associated  with  AD  dRTA  were later  reported 
(Jarolim et al, 1998).  The individuals with this mutation 
had  normal  red  cell  morphology  with  a  slight  decrease 
(~20%) in sulfate influx activity.  kAE1 R589H expressed 





- exchange but the anion transport activities 
between wild-type and  mutant eAE1 were not different.  
No dominant negative behavior on the anion transport ac-
tivity was observed in the co-expression of wild-type and 
mutant eAE1 or kAE1 in the oocytes (Jarolim et al, 1998). 
From screening 26 kindreds with primary dRTA for muta-
tions in SLC4A1, Karet et al (Karet et al, 1998) found no 
mutations  in  this  gene  in  any  of  the  kindreds  with  AR 
dRTA, confirmed by  linkage analysis.   In contrast, het-
erozygous  mutations  in  SLC4A1  were  identified  in  one 
dominant dRTA kindred, one sporadic case, and one kin-
dred  with  two  affected  brothers.    In  these  individuals, 
SLC4A1 R589S, de novo R589H, or R901X due to an in-
tragenic 13-bp duplication resulting in deletion of the last 
11  amino  acids  of  AE1  (band  3  Walton),  respectively, 
were identified, indicating the key role of Arg589 and the 
C terminus in normal AE1 function.  However, the sugges-
tion in this paper that the defects in SLC4A1 were not re-
sponsible for AR dRTA has been proved incorrect by the 
subsequent studies of AR dRTA associated with SLC4A1 
mutations in Thai and other Southeast Asian populations 
(Tanphaichitr et al, 1998; Vasuvattakul et al, 1999; Bruce 
et al 2000; Wrong et al, 2002; Yenchitsomanus et al, 2002; 
Yenchitsomanus, 2003) (Table 1). 
 
Two novel SLC4A1 mutations resulting in AD dRTA were 
recently  reported.    A  heterozygous  novel  mutation  oc-
curred from a 20-bp deletion in exon 20 of SLC4A1 lead-
ing to mutation in codon 888 followed by a premature ter-
mination codon at position 889 (A888L+889X), truncating 
the protein by 23 amino acids, was identified in two af-
fected brothers with dRTA, nephrocalcinosis, and failure 
to thrive, and in their father who had incomplete dRTA 
(Cheidde et al, 2003).  A novel missense G609R mutation 
causing AD dRTA was reported in affected members of a 
large  Caucasian  pedigree  who  all  exhibited  dRTA  with 
prominent nephrocalcinosis and progressive renal impair-
ment (Rungroj et al, 2004) and AD dRTA in this family 
was not associated with loss of anion transport function of 
the  mutant  protein  but  associated  with  its  mis-targeting 
which will be discussed later.  
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The results of these studies clearly indicate that SLC4A1 
mutations can cause AD dRTA.  However, the molecular 
mechanism of AD dRTA was mainly unclear.  Although 
the  SLC4A1  mutations  were  found  to  be  co-segregated 
with the disease in the several affected families, the mutant 
proteins  did  not  have  significantly  functional  change  as 
examined in red cells and Xenopus oocytes.  This indicated 
that the defects are not simply a loss of anion transport 
activity  but  probably  caused  by  other  mechanisms,  and 
that these two cell types might not serve as good systems 
for studying the defects, because the mutant AE1 proteins 
could move to the surface  of the red cells and  oocytes, 
mediating normal transport activities.  It was found in the 
subsequent studies using transfected cell systems that traf-
ficking  defects  of  mutant  kAE1  proteins  are  the  major 
pathogenic mechanisms. 
 
Autosomal recessive distal renal tubular acidosis (AR 
dRTA) 
The SLC4A1 mutation associated with AR dRTA was first 
reported in two Thai sibs (Tanphaichitr et al, 1998) who 
had hemolytic anemia and abnormal red cells with xero-
cyte-like dumbbell morphology but normal red cell AE1 
content and anion transport activity.  They were found to 
carry a homozygous SLC4A1 mutation resulting in a sub-
stitution of glycine by aspartic acid at position 701 in the 
AE1 protein (G701D), namely band 3 Bangkok I, which 
also links to two polymorphisms, M31T and K56E.  When 
expressed  in  Xenopus  oocyte,  both  eAE1  and  kAE1 
G701D showed lack of cell surface expression and anion 
transport activity.  When co-expressed with a red cell AE1 
chaperone, glycophorin A (GPA), the plasma membrane 
expression and chloride influx activity of eAE1 and kAE1 
G701D  could  be  rescued.    Thus,  in  patients’  red  cells 
which  normally  contain  GPA,  eAE1  G701D  will  have 
surface expression and function, explaining the normal red 
cell anion transport activity.  The renal phenotype is ex-
plained  by  the  absence  of  GPA  expression  in  the  α-
intercalated cells.  Severe hemolytic anemia and red cell 
abnormality in the two affected sibs in this family are most 
likely due to the presence of both homozygous SLC4A1 
G701D  mutation  and  homozygous  hemoglobin  (Hb)  E, 
because the finding of severe hemolytic anemia were not 
observed, but only slight red cell changes were noted, in 
seven patients with homozygous SLC4A1 G701D mutation 
without homozygous Hb E from five additional Thai fami-
lies studied (Yenchitsomanus et al, 2002).  The homozy-
gous  SLC4A1  G701D  mutation  seems  to  be  a  frequent 
cause of AR dRTA in Thai pediatric patients from north-
eastern Thailand (Yenchitsomanus et al, 2002). 
 
The presence of both SLC4A1 SAO and G701D mutations 
in Thai and Southeast Asian populations leads to the pos-
sibility  of  compound  heterozygosity  of these  two  muta-
tions in the same individual.  Two cases of AR dRTA and 
SAO  resulted  from  compound  heterozygous  SLC4A1 
SAO/G701D  mutations  were  originally  reported  in  two 
Thai families from southern Thailand (Vasuvattakul et al, 
1999).  These patients were not anemic but had little mor-
phological changes of red cells in addition to SAO, and 
had a decrease of red cell sulfate flux of about 40%.  As 
hemopglobinopathies  (e.g.,  Hb  E),  and  thalassemias  are 
highly  common  genetic  defects  in  Thailand  and  other 
Southeast Asian countries and as the interaction between 
homozygous SLC4A1 G701D mutation and homozygous 
Hb E appeared as an example in the first Thai family re-
ported (Tanphaichitr et al, 1998),  other types of  genetic 
interaction  within  the  same  individual  would  be  antici-
pated.    Indeed,  two  additional  families  with  AR  dRTA 
caused  by  the  compound  heterozygous  SLC4A1 
SAO/G701D genotype from the central Thailand and co-
existence of thalassemias leading to dRTA and anemia are 
recently  observed  by  our  group  (Yenchitsomanus  et  al, 
data to be published).  The presence of Thai families with 
compound heterozygous SLC4A1 SAO/G701D mutations 
most likely occur from a mixture between the northeastern 
Thai population that has a high frequency of the G701D 
mutation, and the southern Thai population that has a high 
frequency of SLC4A1 SAO (Yenchitsomanus et al, 2003).  
The  southward  migration  of  the  SLC4A1  G701D  allele 
seems to reach as far as Malaysia. 
 
Three patients with AR dRTA with compound heterozy-
gous SLC4A1 SAO/G701D mutations were later reported 
in two Malaysian families, and AR dRTA in another pa-
tient  from  a  Malaysian  family  resulted  from  compound 
heterozygous  SLC4A1  SAO/A858D  mutations  (Bruce  et 
al, 2000).  In the same study, AR dRTA associated with 
other  genotypes  including  SAO/∆V850,  ∆V850/∆V850, 
and  ∆V850/A858D  was  observed  in  patients  from  six 
Papua New Guinean families.  Hemolytic anemia and ab-
normal  red  cell  properties  were  noted  in  these  patients.  
Red cell and Xenopus oocyte expression studies showed 
that  the  AE1  ∆V850  and  A858D  mutant  proteins  have 
greatly  decreased  anion  transport  when  present  as  com-
pound  heterozygotes  (∆V850/A858D,  SAO/∆V850  or 
SAO/A858D) with only 3% of the normal red cell sulfate 
efflux for SAO/A858D, the lowest anion transport activity 
reported.  Similar to the heterozygous SLC4A1 mutation 
causing band 3 PRIBRAM (Rysava et al, 1997), the het-
erozygous  A858D  mutation  was  found  to  be  associated 
with  incomplete  dRTA.    The  complete  dRTA  was  ob-
served  in  compound  heterozygous  (∆V850/A858D  or 
SAO/A858D) genotypes.  The mutant AE1 A858D protein 
seems to possess a greater structural or functional abnor-
mality  than  other  mutant  AE1  proteins  resulting  in  AR 
dRTA.  SLC4A1 A858D has been, however, assigned as a 
mutation causing AD dRTA by the first reporting group 
(Bruce et al, 2000).  It should be noted that the dominant 
and  recessive  diseases  are  generally  defined  by  clinical 
phenotypes,  which  may  be  variable  in  expressivity  and 
penetrance and can also be modified by the effect of other 
genes.  On the other hand, abnormal laboratory findings 
can be observed in the heterozygous carriers of recessive 
diseases that usually present normal phenotypes. 
 
The presence of the homozygous  V488M (band 3 Coim-
bra) mutation causing severe HS and dRTA in a  young 
Portuguese child (Ribeiro et al, 2000) further confirms the 
AR  form  of  dRTA  associated  with  SLC4A1  mutations.  
Two additional novel SLC4A1 mutations in 3 patients with 
AR dRTA from 2 unrelated Thai families were recently 
reported by our group (Sritippayawan et al, 2004).  In the 
first  family,  the  patient  with  dRTA,  rickets,  failure  to 
thrive  and  nephrocalcinosis,  had  novel  compound  het-
erozygous G701D/S773P mutations.  In the second family,  
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the patient and his sister had dRTA and SAO of different 
clinical severity. While the patient had rickets, nephrocal-
cinosis, hypokalemia, metabolic acidosis, and inappropri-
ately high urine pH, his sister was asymptomatic and not 
acidotic but her urine pH level could not be lowered to 
below 5.5 after a short acid load i.e. incomplete dRTA.  
Both  siblings  had  compound  heterozygous  SLC4A1 
SAO/R602H  mutations  but  the  cause  of  this  different 
clinical severity is unknown.  It might be an example of 
the variable expressivity of dRTA phenotype attributable 
to  a  modifier  gene.    The  AE1  S773P  and  R602H  are 
named band 3 Siriraj I and Songkla I, respectively (Sritip-
payawan et al, 2004).  The locations of SLC4A1 mutations 
causing AR dRTA are also shown in Figure 2. 
 
It is obvious that AD dRTA caused by SLC4A1 mutations 
was  mainly  found  in  occidental  patients  whereas  AR 
dRTA associated with SLC4A1 mutations was frequently 
detected  in  oriental  patients.    The  possibility  that  the 
SLC4A1 mutations discovered in Southeast Asian popula-
tions  might  have  evolved  locally  because  they  provide 
some protection against the clinical effects of Plasmodium 
falciparum malaria as occurs with the SLC4A1 mutation 
that  gives  rise  to  SAO  has  been  raised  (Wilairat,  2000; 
Bruce et al, 2000). 
 
MOLECULAR  MECHANISMS  OF  AD  dRTA 
CAUSED BY SLC4A1 MUTATIONS 
 
The molecular mechanisms of AD dRTA associated with 
two  SLC4A1  mutations,  R589H  and  R901X  (band  3 
Walton),  have  been  intensively  examined.    Quilty  et  al 
(Quilty  et  al,  2002a  and  2002b)  has  demonstrated  that 
dominant negative effect would account for the AD dRTA 
phenotype.    eAE1,  eAE1  R589H,  and  kAE1  were  ex-
pressed at the cell surface of transfected HEK 293 cells, 
whereas  kAE1  R589H  was  retained  intracellularly  as 
shown by immunofluorescence, cell surface biotinylation, 
N-glycosylation, and anion transport assays (Quilty et al, 



































Figure 2.  The SLC4A1 gene and locations of mutations (upper panel).  Filled and unfilled vertical bars (or rectangle) represent cod-
ing and non-coding exons, respectively.  Horizontal lines between the filled and unfilled vertical bars represent introns.  Approximate 
locations of mutations in exons are pointed by arrows and types of amino acid change due to mutations are indicated at the tails of 
arrows.  The structural model of AE1 protein and positions of amino acid alterations (lower panel).  Each circle and alphabet repre-
sent amino acid in AE1.  An incomplete N-terminal domain of AE1 is shown.  This AE1 model consists of 13 transmembrane (TM) 
domains (Zhu et al, 2003).  The positions of amino acid change due to mutations are pointed by arrows and types of amino acid al-
terations are indicated at the tails of arrows.  SAO denotes Southeast Asian ovalocytosis.  PRIBRAM is AE1 PRIBRAM (an 
IVS12+1G>T substitution causing an mRNA splicing defect with intron 12 retention and premature termination of protein synthesis), 
Arg589 can be changed to either histidine (R589H), cysteine (R589C) or serine (R589S).  
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kAE1 was likely due to its retention in the endoplasmic 
reticulum (ER).  Co-expression of kAE1 R589H reduced 
the cell surface expression of wild-type kAE1 and eAE1 
due  to  heterodimer  formation  and  a  dominant-negative 
effect.  The mutant eAE1 and kAE1 were not grossly mis-
folded  as  they  could  bind  to  an  inhibitor  affinity  resin.  
Other SLC4A1 mutations at the same position (R589C and 
R589S) also prevented the targeting of kAE1 to the cell 
surface, indicating that the normal Arg589, which is evolu-
tionary conserved, is important for proper trafficking.  In 
studies using transfected and virally infected MDCK cells 
originating from principal cells, two groups have similarly 
observed that the mutant kAE1 R589H and kAE1 S613F 
retain in ER of the non-polarized cells and also that they 
distribute throughout the cells with a failure to reach the 
cell surface in the polarized cells (Toye et al, 2004; Cordat 
et al, 2005). A co-expression study in MDCK cells showed 
that  the  kAE1  R589H  similarly  retained  the  wild-type 
kAE1 intracellularly, probably through heterodimer forma-
tion (Cordat et al, 2005). 
 
The properties of kAE1 R901X expressed in Xenopus oo-
cytes,  non-polarized  MDCK,  and  HEK  293  cells  have 
been  examined  (Toye  et  al,  2002;  Quilty  et  al,  2002b).  
kAE1  R901X  had  a  normal  chloride  transport  activity 
when expressed in Xenopus oocytes.  While normal kAE1 
was expressed at the cell surface in the cultured kidney 
cell  line,  the  kAE1  R901X  was  retained  intracellularly 
within the cultured cells, indicating that the C-terminal tail 
of AE1, which is truncated in kAE1 R901X, is required for 
its movement to the cell surface in kidney cells.  It was 
proposed  (Toye  et  al,  2002)  but  not  proved  that  kAE1 
R901X  gives  rise  to  dominant  dRTA  by  inhibiting  the 
movement of normal kAE1 to the cell surface, resulting 
from the association of the normal and mutant proteins in 
kAE1 hetero-oligomers.  It was truly proved by Quilty et 
al (Quilty et al, 2002b) that this dominant-negative effect 
was due to hetero-oligomer formation of the mutant and 
wild-type proteins, because co-expression of the wild-type 
and  mutant  kAE1,  or  eAE1  R901X,  indeed  resulted  in 
intracellular retention of the wild-type proteins in a pre-
medial Golgi compartment in the expression experiments 
using transiently transfected HEK 293 cells.  A series of 
truncations at the C-terminus of AE1 also resulted in im-
paired ER exit, depending on the extent of the truncation 
(Cordat et al, 2003).  Intracellular retention of kAE1 in the 
renal α-intercalated cells by the dRTA mutant would ac-
count  for  the  impaired  bicarbonate  extrusion  to  inter-
stitium and acid secretion into the urine that is characteris-
tic of dRTA.  
 
The  distribution  of  epitope-tagged  full-length  wild-type 
and AE1 R901X was examined in polarized MDCK cells 
and rat IMCD cells (which express AE1) (Devonald et al, 
2003a).  In both cell types, the wild-type AE1 localized to 
the  basolateral  plasma  membrane  domain  whereas  AE1 
R901X was found at both the basolateral and apical cell 
surfaces  as  well  as  intracellularly,  suggesting  that  AD 
dRTA is caused not only by a decrease of AE1 protein at 
the basolateral surface but also by its inappropriate pres-
ence at the apical surface.  The apical chloride and bicar-
bonate flux would alter electrochemical balance across the 
cell, impairing both unidirectional basolateral bicarbonate 
extrusion and apical proton secretion.  The non-polarized 
distribution of mutant AE1 could be explained by the loss 
of a basolateral targeting signal present in the deleted por-
tion of its C terminus.  The motif YDEV (904–907) pre-
sent in the tail of AE1 conforms to a subset of tyrosine-
based targeting motifs, YXXØ.  When Tyr904 was mu-
tated to alanine (Y904A), the distribution of protein was 
similar to that of AE1 R901X.  YXXØ motifs interact with 
µ  subunits  of  adaptor-protein  complexes,  one  of  which, 
AP-1B, is specific to polarized epithelial cells.  Whether 
sorting of AE1 depends on AP-1B or not was investigated 
in the proximal renal tubular cell line, LLC-PK1, which 
was reported to lack the µ1B subunit and thus cannot form 
AP-1B complexes.  The results suggested that an adaptor 
protein other than AP-1B is involved in basolateral sorting 
of AE1 (Devonald et al, 2003a). 
 
The mis-targeting to the apical membrane of kAE1 R901X 
in stably transfected polarized MDCKI cells was also con-
firmed in a subsequent study, and it was similarly demon-
strated that the 11 C-terminal residues of kAE1 containing 
a tyrosine-dependent basolateral targeting signal was not 
recognized  by  µ1B-containing  AP-1  adaptor  complexes 
(Toye et al, 2004).  In addition, in the absence of the N-
terminus  of  kAE1,  the  C-terminus  was  not  sufficient  to 
localize  kAE1  to  the  basolateral  membrane,  suggesting 
that  a  determinant  within  the  kAE1  N-terminus  co-
operates with the C-terminus for kAE1 basolateral local-
ization (Toye et al, 2004 and 2005). 
 
A  missense  SLC4A1  mutation,  glycine  609  to  arginine 
(G609R), giving rise to AD dRTA was reported in an ex-
tended Caucasian family (Rungroj et al, 2004).  The kAE1 
G609R expressed on the cell surface of Xenopus oocytes 
maintained normal anion transport function.  In contrast to 
the normal basolateral localization of wild-type kAE1, the 
mutant  kAE1 G609R was partailly located at the apical 
and  sub-apical  membrane,  and  also  at  the  basolateral 
membrane in polarized MDCK cells, similar to the kAE1 
R901X.  Gly609 may play a role in kAE1 protein traffick-
ing.    Since  this  residue  is  close  to  Arg589  and  Ser613 
where their missense mutations cause AD dRTA, this re-
gion of AE1 may be involved in the protein trafficking or 
sorting process (Rungroj et al, 2004). The kAE1 G609R 
has  not  been  examined  for  a  dominant-negative  effect, 
which might explain the dominant dRTA phenotype.  In 
analogy  to the  kAE1  R901X,  kAE1  G609R, which was 
similarly mis-targeted in the polarized MDCK cells, may 
also intracellularly retain the wild-type kAE1 protein. 
 
MOLECULAR  MECHANISMS  OF  AR  dRTA 
CAUSED BY SLC4A1 MUTATIONS 
 
Based on the previous study of kAE1 G701D in Xenopus 
oocyte (Tanphaicitr et al, 1998; Bruce et al, 2000) showing 
functional mutant protein with defective trafficking to the 
cell surface, we propose two possible models for the mo-
lecular mechanism of AR dRTA caused by SLC4A1 muta-
tions.  Firstly, in the heterozygous state, the mutant kAE1 
per se is unable to form homo- and heterodimers and so 
would be unable to traffic to the cell surface.  Thus, only 
the mutant kAE1 is defective, while the wild-type kAE1 is 
still intact.  The wild-type kAE1 would be able to dimerize  
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and traffic to the cell surface, and sufficiently maintain the 
normal  transport  function.    And,  secondly,  in  the  het-
erozygous state, the mutant kAE1 might be able to form 
homo- and heterodimers, but only the homodimer would 
be defective in trafficking to the cell surface.  In the sec-
ond model, the heterodimer of the mutant and wild-type 
kAE1 proteins would be able to traffic to the cell surface 
and  would  not  exhibit  the  dominant-negative  effect,  as 
observed in AD dRTA. 
 
Since  a  novel  compound  heterozygous  SLC4A1 
G701D/S773P  mutation  was  recently  reported  by  our 
group in the Thai patient with AR dRTA (Sritippayawan et 
al, 2004), the S773 and G701D mutations were then used 
as examples for the study in order to elucidate the molecu-
lar mechanism of AR dRTA caused by SLC4A1 mutations, 
and to examine the two proposed models.  The biosynthe-
sis and trafficking of kAE1 S773P were studied in tran-
siently transfected HEK 293 cells, expressing the mutant 
alone  or  in  combination  with  wild-type  kAE1  or  kAE1 
G701D (Kittanakom et al, 2004).  It was found that kAE1 
S773P was expressed at only a third the level of the wild-
type kAE1, had a two-fold decrease in its half-life, and 
was targeted for degradation by the proteasome.  The mu-
tant protein could not be detected at the plasma membrane 
of  transfected  HEK  293  cells  and  showed  predominant 
immunolocalization in the ER of both HEK 293 and LLC-
PK1 cells. 
 
The  oligosaccharide  on  a  kAE1  S773P  N-glycosylation 
mutant  (N555)  was  not  processed  to  the  complex  form 







Figure 3.  The molecular and cellular model for dominant and recessive dRTA in polarized epithelial cells.  Schematic model of 
epithelial cells expressing wild-type kAE1, dominant or recessive mutants in homozygous (left model) or heterozygous state (right 
model).  Dimers of wild-type kAE1 (burgundy ovals) traffic to the basolateral membrane (solid line) while dominant dRTA mutants 
(brown ovals) are retained in the ER.  Recessive dRTA mutants (green ovals) are partially impaired (dotted lines) in their exit from 
the ER but can either traffic to the basolateral membrane or are retained in the Golgi apparatus.  Heterodimers of wild-type kAE1 and 
dominant kAE1 mutant are retained in the ER, while heterodimers of wild-type kAE1 and recessive kAE1 mutants can traffic to the 
basolateral membrane. Theoretically, the proportions of wild-type kAE1 homodimer, heterodimer, and mutant kAE1 homodimer are 
25%, 50% and 25%, respectively.  Therefore, 25% of kAE1 in the dominant model and 75% of kAE1 in the recessive dRTA model 
traffic to the plasma membrane.  TJ denotes tight junction.  
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was not properly folded as it showed decreased binding to 
an inhibitor affinity resin and increased sensitivity to pro-
teases. The kAE1 G701D also exhibited defective traffick-
ing to the plasma membrane.  The kAE1 S773P was able 
to  form  homodimers  and  heterodimers  with  wild-type 
kAE1 or with kAE1 G701D.  Heterodimers of wild-type 
kAE1  with  kAE1  S773P  or  G701D,  in  contrast  to  the 
dominant  mutant  kAE1  R589H,  were  delivered  to  the 
plasma membrane (Figure 3).  Thus, the second proposed 
model is likely to be the true one, and the wild-type kAE1 
seems to show a ‘dominant-positive effect’ in rescuing the 
recessive  mutant  kAE1  trafficking  to  the  plasma  mem-
brane, in contrast with the dominant mutant kAE1 result-
ing in a ‘dominant-negative effect’ when heterodimerized 
with the wild-type kAE1. 
 
In our recent study in MDCK cells (Cordat et al, 2005), we 
found  that  the  recessive  mutants,  kAE1  S773P  and 
G701D,  showed  distinct  trafficking  defects.    The  mis-
folded  recessive  mutant  kAE1  S773P,  while  largely  re-
tained in the ER in non-polarized MDCK cells, was pre-
dominantly targeted to the basolateral membrane in polar-
ized cells while kAE1 G701D was retained in the Golgi in 
both non-polarized and polarized cells.  The co-expression 
study  in  MDCK  cells  confirmed  the  previous  study  in 
HEK  293  cells  that  the  dominant  mutant  kAE1  R589H 
retained wild-type kAE1 protein intracellularly while the 
recessive  kAE1  mutants  did  not.    The  co-expression  of 
kAE1 S773P and G701D in the same cells showed some 
co-localization  of  S773P  with  G701D  in  the  Golgi,  but 
kAE1  S773P  could  still  traffic  to  the  basolateral  mem-
brane.    Also,  no  kAE1  G701D  was  detected  at  the  cell 
surface,  suggesting  that  kAE1  S773P  did  not  assist  the 
intracellularly retained kAE1 G701D to traffic to the cell 
surface as did the wild-type kAE1, despite their ability to 
oligomerize in the MDCK cells.  This result suggests that 
in  the  patients  with  compound  heterozygous  SLC4A1 
G701D/S773P  mutations,  only  the  mis-folded 
S773P/S773P homodimers which may not properly func-
tion can reach the basolateral membrane of the kidney α-




The molecular mechanisms of AD and AR dRTA caused 
by SLC4A1 mutations have now been elucidated (Figure 
3).  The modes of inheritance of dRTA associated SLC4A1 
mutations are primarily dictated by the position of amino 
acid alterations in the encoded kAE1 protein and on some 
occasions by the type of amino acid replacement, affecting 
kAE1  folding  and  molecular  structure  without  signifi-
cantly changing anion exchange function.  The structural 
alterations of mutated kAE1 in both phenotypic conditions 
do not generally interfere with its dimerization as homo- 
and heterodimers.  However, they affect intracellular traf-
ficking of the mutant kAE1 homodimers from the ER and 
trans-Golgi network to the plasma membrane.  Between 
two extremes of normally trafficking of wild-type-kAE1 
homodimer  and  abnormally  trafficking  of  mutant-kAE1 
homodimer, trafficking ability of the heterodimer between 
wild-type  and  mutant  kAE1  in  heterozygous  conditions 
exhibits a key role in determining the dominant or reces-
sive nature of the phenotype.  In AD dRTA, mutant kAE1 
in the heterodimer induces a trafficking defect of wild-type 
kAE1, so called the ‘dominant-negative effect’, leading to 
the  AD  dRTA  phenotype.    By  contrast,  in  AR  dRTA, 
wild-type kAE1 in the heterodimer corrects the trafficking 
defect  of  mutant  kAE1,  a  newly  described  ‘dominant-
positive effect’, producing the AR dRTA phenotype.  In 
the case of AD dRTA, the mutant (R589H, S613F, and 
R901X) homodimers are retained in the ER, as are het-
erodimers with the wild-type kAE1.  The retention of the 
wild-type protein by the heterodimer formation does not 
allow  sufficient  kAE1  to  be localized  to  the basolateral 
membrane.    In  some  cases  (R901X  and  G609R),  the 
dominant mutants can exit the ER and are partially mis-
sorted to the apical membrane, which would also impair 
the  basolateral  bicarbonate  reabsorption  and  apical  acid 
secretion  of the α-intercalated cells.  In the case  of AR 
dRTA,  the  mutant  homodimers  can  traffic  to  the  Golgi 
(G701D) or the basolateral membrane (S773P), but since 
the  latter  protein  is  mis-folded,  no  transport  activity  is 
achieved.  Heterodimers of AR dRTA mutants can form 
with the wild-type kAE1, but in this case can traffic to the 
basolateral  membrane.    The  wild-type  homodimers  that 
form can traffic normally to the basolateral membrane.  In 
the heterozygous state, sufficient wild-type kAE1, either 
as a homodimer or as a heterodimer with an AR dRTA 
mutant, would be present to maintain sufficient bicarbon-
ate reabsorption and acid secretion. 
 
All these findings may serve as an example in the elucida-
tion of molecular mechanisms of AD and AR phenotypes 
of the same disease caused by defects of a common gene; 
to our knowledge this is the first time that the phenotypes 
of the two different modes of inheritance of the same dis-
ease are clearly explained in term of the biochemical prop-
erties of the homodimers and heterodimers of the encoded 
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